Related Experiment Video

Updated: May 6, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

11.6K

An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth

Lucy C Young1, Nicole Hartig1, Marta Muñoz-Alegre1

  • 1UCL Cancer Institute, University College London, London WC1E 6BT, UK.

Molecular Cell
|November 12, 2013
PubMed

Insights

SHOC2 and MRAS proteins form a complex with SCRIB, impacting the ERK-MAPK pathway crucial for cancer cell malignancy and migration. This interaction reveals new therapeutic targets for RAS-mutant tumors.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • SHOC2 mutations are linked to Noonan syndrome.
  • The ERK-MAPK pathway is frequently activated in human cancers.
  • SHOC2 acts as a PP1-regulatory protein and MRAS effector.

Purpose of the Study:

  • To investigate the interaction between SHOC2, MRAS, and SCRIB.
  • To elucidate the role of this complex in cancer cell properties and pathway regulation.
  • To understand the mechanism of SCRIB's antagonism of SHOC2-mediated RAF dephosphorylation.

Main Methods:

  • Co-immunoprecipitation assays to detect protein complex formation.
  • In vitro phosphatase assays to study RAF dephosphorylation.
  • Cellular assays to assess malignant properties and polarized migration.

Main Results:

  • SHOC2 and MRAS form a complex with the polarity protein SCRIB.
  • SCRIB antagonizes SHOC2-mediated RAF dephosphorylation by competing for PP1.
  • SHOC2 is essential for malignant properties and polarized migration in RAS-mutant tumor cells.

Conclusions:

  • MRAS, SHOC2, and SCRIB form a complex that regulates ERK pathway dynamics and cell polarity.
  • This complex is critical for tumorigenic growth and polarized migration in RAS-driven cancers.
  • Targeting this complex may offer therapeutic strategies for cancers with upregulated ERK-MAPK signaling.

More Related Videos

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

2.3K
Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

38.0K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K